This Website uses cookies to provide you with a personalized browsing experience. By using this Website, you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them.

Ophthalmology Treatment and Medicines - Cipla Pharmaceutical

Cipla has a dedicated ophthalmology division with medicines that support wellness, prevention, treatment and cures in a broad range of therapeutic areas which include glaucoma, dry eye, anti-infectives, anti-inflammatory and anti-oxidants.

Working on the belief that eyes are the most complex and delicate organs in the body, we ensure that every eye drop contains a universe of care and commitment, science and technology, passion and precision.

Below are some of our innovative products:

  • World’s first cyclosporine eye drops with micro-emulsion technology.
  • World’s first antibiotic-steroid fixed dose combination.
  • India’s first carbonic anhydrase inhibitors for glaucoma.

Plus we have many more one-of-a-kind products in the pipeline.

World-class quality is reflected in everything we do. Our factories, drugs, dispensers meet the exacting standards of the highest international regulatory agencies – US FDA, MCA-UK, TGA Australia, MCC South Africa, PIC Germany. Our products like Dorzolamide, Latanoprost (glaucoma), Fluorometholone, Fluorometholone-neomycin, Acyclovir, Norfloxacin, Ciprofloxacin (anti-infective) and Polyvinyl alcohol (dry eye) are exported globally to several countries.

Our commitment to a therapy doesn’t stop at making only world-class medicines. We work hand-in-hand with the medical fraternity to educate glaucoma/cataract patients about the disease. We are also actively involved in formulating the guidelines on diseases like glaucoma, infective keratitis, endophthalmitis with the All India Ophthalmology Society.

Cipla Ophthalmology has just one focus - to give you a quality you can trust with your eyes closed.